Synovial changes detected by ultrasound in people with knee osteoarthritis – a meta-analysis of observational studies  by Sarmanova, A. et al.
Osteoarthritis and Cartilage 24 (2016) 1376e1383Synovial changes detected by ultrasound in people with knee
osteoarthritis e a meta-analysis of observational studies
A. Sarmanova y x, M. Hall y z, J. Moses y, M. Doherty y x, W. Zhang y x *
y Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, UK
z School of Health Sciences, University of Nottingham, UK
x Arthritis Research UK Pain Centre, Nottingham, UKa r t i c l e i n f o
Article history:
Received 26 October 2015
Accepted 3 March 2016
Keywords:
Ultrasound
Synovial
Osteoarthritis
Meta-analysis
Synovitis* Address correspondence and reprint requests to
matology, Clinical Sciences Building, City Hospital, No
E-mail address: weiya.zhang@nottingham.ac.uk (W
http://dx.doi.org/10.1016/j.joca.2016.03.004
1063-4584/© 2016 The Authors. Published by Elsevie
(http://creativecommons.org/licenses/by/4.0/).s u m m a r y
Objectives: To examine the prevalence of synovial effusion, synovial hypertrophy and positive Doppler
signal (DS) detected by ultrasound (US) in people with knee osteoarthritis (OA) and/or knee pain
compared to that in the general population.
Method: A systematic literature search was undertaken in Medline, EMBASE, Allied and Comple-
mentary Medicine, PubMed Web of Science, and SCOPUS databases in May 2015. Frequencies of US
abnormalities in people with knee OA/pain, in the general population or asymptomatic controls were
pooled using the random effects model. Publication bias and heterogeneity between studies were
examined.
Results: Twenty four studies in people with knee pain/OA and ﬁve studies of the general population or
asymptomatic controls met the inclusion criteria. The pooled prevalence of US effusion, synovial hy-
pertrophy and positive DS in people with knee OA/pain were 51.5% (95% CI 40.2 to 62.8), 41.5% (26.3
e57.5) and 32.7% (8.34e63.24), respectively, which were higher than those in the general population or
asymptomatic controls (19.9% (95%CI 7.8e35.3%), 14.5% (0e58.81), and 15.8 (3.08e35.36), respectively).
People with knee OA (ACR criteria or radiographic OA) had greater prevalence of US abnormalities than
people with knee pain (P ¼ 0.037, P ¼ 0.010 and P ¼ 0.009, respectively).
Conclusions: US detected effusion, synovial hypertrophy and DS are more common in people with knee
OA/pain, compared to the general population. These abnormalities relate more to presence of OA
structural changes than to pain.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Pathologically osteoarthritis (OA) is characterised by involve-
ment of all joint tissues, typically with focal cartilage loss, osteo-
phyte formation, subchondral bone remodelling, and synovial and
capsular thickening. Although synovial hyperplasia in knees
affected by OA is focal and less marked than in knees with rheu-
matoid arthritis it may still play an important role in disease
pathogenesis1,2. Cohort studies have shown a positive association
between synovial pathology and disease progression3e5. Therefore
whether synovitis is a potential biomarker of inﬂammatory: W. Zhang, Academic Rheu-
ttingham NG5 1PB, UK.
. Zhang).
r Ltd on behalf of Osteoarthritis Reresponse and therapeutic target in OA is an important research
question2.
Ultrasound (US) imaging is used widely because it is non-
invasive, has no radiation burden, is relatively inexpensive, in-
volves a short examination time, and has good patient accept-
ability6. US detection of synovial effusion and synovial hypertrophy
in knees is reported to be more sensitive than clinical examina-
tion7,8, correlates well with histological ﬁndings9,10 and is equiva-
lent to MRI in visualising effusion11,12. Strong perfusion (i.e.,
Doppler signal (DS)) is associated with clinical signs of inﬂamma-
tion (soft tissue swelling, tenderness, increased warmth) and also
with histological and laboratory markers of inﬂammation (e.g.,
serum C-reactive protein) in people with inﬂammatory
arthritis13,14.
A number of predominantly hospital-based studies have been
undertaken in knee OA to examine US detected abnormalities.
However, the normal values, thresholds and frequencies of thesesearch Society International. This is an open access article under the CC BY license
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with knee pain or OA remain largely unknown. Therefore, it is of
interest to systematically review studies of synovial effusion, sy-
novial hypertrophy and positive DS in the general population and in
people with knee pain or knee OA and, if possible, the prevalence
and associations of such changes.
Materials and methods
Data sources and search strategy
Two systematic literature searches were performed using
computer-based literature indexes such as Medline (1946e),
EMBASE (1974e), Allied and Complementary Medicine (1985e),
PubMed (1960e), Web of Science, and SCOPUS (1960e) in May,
2015. Citations and abstracts retrieved from this search were
downloaded to EndNote X6.0.1 (licenced to The University of
Nottingham).
The ﬁrst search included (a) OA of the knee, and (b) US. The
search terms were ‘‘[ultrasound or sonography or ultrasonography
or doppler or dopplerography or power-doppler] and [knee oste-
oarthritis or knee osteoarthrosis or gonarthritis or gonarthrosis or
knee pain or ((osteoarthritis or osteoarthrosis or osteophyte or joint
space narrowing or degenerative joint disease(s)) and knee)]’’
(Supplementary ﬁle 1).
The second search was performed for studies that have explored
prevalence of synovial changes in the general population irre-
spective of knee pain or knee OA using terms “[knee(s) and [ul-
trasound or sonography or ultrasonography or doppler or
dopplerography or power-doppler] and [normal or healthy or
general or population-based]” (Supplementary ﬁle 1).
Selection criteria
Observational studies were included if they examined US-
detected synovial effusion, synovial hypertrophy, or DS detected
in people with knee pain/OA, in the general population or in
normal/healthy controls. If studies were based on the same par-
ticipants and same outcome measures, only one publication with
the most detailed information was included in the review. There
were no language restrictions.
Randomised controlled trials, studies in selected groups with
synovial effusion or synovial hypertrophy, studies without clear
deﬁnition of US-detected pathology (for example “synovitis”
without descriptionwhether it is related to synovial hypertrophy or
combined measure of effusion and hypertrophy), or studies not
reporting the prevalence estimate were excluded as they cannot
provide an adequate estimate of prevalence. Although reviews and
conference proceedings were not included their references were
cross-checked.
Data extraction and outcome measures
For each included article information on authors, year of pub-
lication, study design (cross sectional, case control), population
(hospital, community), sample size, age, gender, body mass index
(BMI), diagnostic criteria (e.g., American College of Rheumatology
(ACR)), radiographic score (e.g., Kellgren and Lawrence score
(K&L)), and US ﬁndings were systematically extracted using a
speciﬁcally developed data extraction form and then transferred to
a database.
The primary outcome measure was frequency/prevalence of US
effusion, synovial hypertrophy and DS in people with knee pain/OA
and in a control or general population derived directly or indirectly
from information provided in each study. The secondary outcomemeasurewas the association of US featureswith OA clinical features
(pain, impaired function) and radiographic structural damage.
Scores for pain intensity were standardised to a common 0 (no
pain) to 100 (worse pain) scale.
Quality assessment
The Newcastle-Ottava Scales (NOS) were used for caseecontrol
and cross-sectional studies15 as recommended by the Cochrane
Non-Randomized Studies Methods Working Group16. Three main
criteria were assessed: participant selection and representative-
ness, comparability of study groups, and assessment of outcome or
exposure. The quality score is based on a “star” system (range 0e9
stars for caseecontrol studies and from 0 to 10 for cross-sectional
studies) with a higher score representing better methodologic
quality. The percentage of the maximum score achieved was used
to present the quality of each study.
Statistical analysis
To derive a pooled estimation of prevalence across different
studies, the random effects meta-analysis was undertaken using
the METAPROP package (with the FreemaneTukey double arcsine
transformation and exact binominal conﬁdence intervals for
prevalence). Heterogeneity between studies was measured using
the I2 and Q test17e19. 95% conﬁdence interval (CI) and P value of
0.05 were used for a statistically signiﬁcant inference. Publication
bias was assessed using funnel plots and Eggers test20. If the
number of studies included in themeta-analysis was too small (4)
the Harbord test was applied to measure publication bias21. Sta-
tistical analysis was undertaken in Stata SE V13.1 (StataCorp LP,
College Station, TX, USA)22,23.
Results
Selection of studies
The ﬁrst search yielded 4149 titles and abstracts, of which 65
potentially relevant publications were considered for full-text
assessment. Forty-one studies were excluded by reading full-text
papers, leaving a total of 24 studies which met the inclusion
criteria. The second search returned 4479 citations of which only
three met inclusion criteria and two additional studies were
identiﬁed from the reference search (Fig. 1). All studies were pub-
lished between 1990 and 2015. Three studies were translated from
German, Italian and Russian24e26, other studies were written in
English.
Characteristics of studies
Data for prevalence were derived from both cross-sectional and
caseecontrol studies. Of 24 studies reporting the prevalence of US-
detected effusion, synovial hypertrophy and DS in people with knee
pain/OA, 14 were caseecontrol and 10 were cross-sectional in
design. Only four studies were community-based, the rest recruited
participants from hospital populations except for four studies
which did not declare the setting11,27e29. The sample size ranged
from 10 to 600 with nine studies reporting a sample size of more
than 100. Age varied from 36 to 74 years. There were 20 studies of
people with symptomatic knee OA (deﬁned by ACR criteria) and
four studies of people with knee pain irrespective of any underlying
structural change. Three studies comprised more than one study
group30e32.
Four cross-sectional studies and one caseecontrol study (in
comparison with rheumatoid arthritis) explored prevalence and
Fig. 1. Study selections.
Table I
Characteristics of the included studies
People with knee OA/pain* General/normal population
Number of studies 24 5
Number of subjects 3713 1007
Mean age (years) 61.05 52.74
Women (%) 75.03 48.93
Mean BMIy (kg/m2) 28.2 25.33
* Including control groups.
y
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pain-free volunteers24,25,35. None of these ﬁve studies obtained
radiographic data. Three of the ﬁve studies (range 50e488)
recruited more than 100 subjects33e35. Age range was from 37 to 73
years.
Ten of the 29 studies were funded from academic sources, one
declared no funding, one had commercial support and others did
not specify funding resources. Baseline demographic character-
istics (age, gender, BMI, pain assessment and radiographic score)
were generally well reported. Table I summarises the main char-
acteristics of included studies. More details are in Supplementary
ﬁle 2.
Deﬁnitions of US pathology varied from dichotomous measures
(with different thresholds) to individual scoring systems (0e3 or
0e4 scale) or summative quantitative systems (adding effusion,
synovial thickness and/or DS). Supplementary ﬁle 3 provides an
overview of US scoring systems used in these studies.Study quality assessment
Of 24 studies in people with knee OA/pain 12 had a score of
50%. In cross-sectional studies the Newcastle-Ottava quality
scores ranged from 2 to 9 stars with a median score of 5.5
(maximum 10). Three studies scored less than ﬁve28,36,37. InBMI e body mass index.
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adequate deﬁnition of cases (ACR-criteria for OA diagnosis or vali-
dated tool for knee pain assessment) and blinded US assessment.
The scores on each of the seven criteria and total scores for each
study are presented in Supplementary ﬁle 4-1.
The quality of the caseecontrol studies varied from 1 to 6 stars
with a median score of 4 (maximum 9) (Supplementary ﬁle 4-2).
Overall themajority of studies had an adequate case deﬁnition (ACR
criteria or radiographic OA). The deﬁnition of controls included no
history of joint disease and no OA as deﬁned.
Prevalence of US features in people with knee OA/pain
Of the 24 included studies, 21 had data for effusion, 13 for hy-
pertrophy and 7 for DS. The pooled prevalence was 51.5%, 41.5% and
32.7%, respectively (Table II). Studies were highly heterogeneous,
but only studies involved in the meta-analysis for hypertrophy had
signiﬁcant publication bias (Table II).
Several subgroup analyses were undertaken according to US
threshold for abnormality, sample size of study, overall quality of
study and deﬁnition of OA. The results are summarised in Table III.
In general larger studies (100) tended to give a lower prevalence
than smaller studies (<100). Similarly, higher quality studies
(overall score 50%) tended to have a lower prevalence than lower
quality studies (overall score <50%). This was especially true when
DS was assessed, where a clear separation was observed between
higher and lower quality studies (Fig. 2). Interestingly, people with
either ACR or radiographic knee OA had greater prevalence of all
three US abnormalities than people with knee pain (Table III).
Prevalence of US features in the general/normal population
Among ﬁve studies identiﬁed from the second search, two
provided data on prevalence of US detected synovial effusion in the
general population33,34. In addition, four normal (i.e., asymptom-
atic) control groups from the case control studies11,27,30,38 reported
prevalence of US synovial effusion. These made a total number of
six studies in this analysis (Table II). The pooled prevalence of US
synovial effusion was 19.9% (95%CI 7.8e35.3%), approximately 2e3
times lower than that in people with knee OA/pain (51.5%, 95%CI
40.2e62.8%, Table II). Similarly, four studies11,27,30,34 provided data
for hypertrophy and two studies30,34 for DS. The prevalence of these
ﬁndings was much lower in the general/normal population than in
people with knee OA/pain. The studies were highly heterogeneous
but had no evidence of publication bias (Table II).
Associations of US-detected synovial changes with pain and
structural changes
Ten studies examined the relationship between knee pain and
US-detected synovial changes. Overall, the most studies reported aTable II
Prevalence of US-detected ﬁndings in people with knee OA/pain
Number of studies Number of subjects
People with knee OA/pain
Effusion 21 3266
Synovial hypertrophy 13 1785
DS 7 538
The general/normal population
Effusion 6 922
Synovial hypertrophy 4 601
DS 2 533
CI: conﬁdence interval; I2: inconsistency; Pheter: p for heterogeneity; Ppub: p for publicat
* Egger's test.
** Harbord's test.positive association between knee effusion and pain (7 of 10
studies) and no association between synovial hypertrophy and pain
(4 of 6), but there were no data for DS (Table IV).
Three studies examined knee pain on walking and at rest
separately32,38,39. Two studies did not ﬁnd any association between
knee effusion and pain at rest32,39, whereas this association was
observed by Naredo (2005)38. Both studies examined synovial hy-
pertrophy but found no association with pain on walking and in-
deﬁnite results with pain at rest32,39. Unfortunately these studies
did not provide sufﬁcient data for statistical pooling so the strength
of the association between knee pain and US effusion/synovial
hypertrophy remains unknown.
Only two studies examined the relationship between Doppler
activity and pain, both recruited people with symptomatic knee OA
with disease duration more than 6 months. Song (2009)40 found a
positive correlation (r ¼ 0.366; P ¼ 0.020) between DS and knee
pain in people with moderate to severe knee pain (mean pain score
e 68.3 (SD 19.6)) and structural changes on radiographs (K&L 2).
A study by Iagnocco (2010)41 revealed a signiﬁcant association
between total US score (effusion, synovial hypertrophy and DS
score in both knees) and pain (P ¼ 0.004) in participants with knee
pain more than 20 mm on a 100 mm VAS scale (mean pain score
48.4 mm (SD 19.9).
Three studies examined the association between US-detected
abnormalities and radiographic severity30,32,42. A positive associa-
tion was observed in two studies which directly addressed the
association between synovial changes and radiographic
severity30,42. For example, knee effusion or abnormal synovial
thickness on US were associated with radiographic OA, deﬁned as
K&L 3 in one study with ORs of 1.91 (95% CI 1.32 to 2.77) and 2.2
(95% CI 1.33 to 3.64), respectively42. This association was inde-
pendent of pain, whereas the association between US features and
pain was highly dependent on the severity of radiographic changes
and only signiﬁcant in people without OA (K&L 2). These ﬁndings
were supported by a recent study by Hall (2014)30, in which four
groups (normal control, knee pain only, radiographic knee OA (K&L
2) only, and knee pain plus radiographic OA) were compared. This
study found no difference between the normal control and knee
pain group, but signiﬁcantly higher scores in both the asymptom-
atic radiographic OA and symptomatic radiographic OA groups. The
prevalence was 29%, 32%, 81%, and 92% for effusion (4 mm); 8%,
12%, 41% and 82% for hypertrophy (4mm); and 2%, 3%, 6% and 16%
for DS (any grade), respectively. In addition, this study followed
participants for 3 months and found no association between
change in pain and change in US features. The study of Wu (2012)32
did not explore directly the association between US ﬁndings and
structural changes. Participants with knee OA who had bilateral
equal K&L scores showed signiﬁcant differences between symp-
tomatic and asymptomatic knees (P ¼ 0.016 for effusion and
P < 0.001 for synovial hypertrophy), suggesting that synovialPooled prevalence (95% CI) I2% (Pheter) Ppub
51.5 (40.2e62.8) 97.5 (<0.0001) 0.082*
41.5 (26.3e57.5) 97.6 (<0.0001) 0.026*
32.7 (8.34e63.24) 98.0 (<0.0001) 0.493*
19.9 (7.81e35.34) 94.7 (<0.0001) 0.587*
14.5 (0e58.81) 98.7 (<0.0001) 0.118**
15.8 (3.08e35.36) 93.8 (<0.001) e
ion bias.
Table III
Subgroup analysis in studies on people with knee OA/pain
Subgroup analysis Effusion Synovial hypertrophy DS
Number of studies Prevalence (95% CI) P* Number of studies Prevalence (95% CI) P* Number of studies Prevalence (95% CI) P*
Threshold
4 mm 11 52.5 (38e66.8) 10 43.1 (26.5e60.5)
2 mm 7 67.6 (55.8e78.3) 2 25.5 (14.5e38.2)
Absent or present 6 32.7 (13.9e54.9) 0.018 3 46.9 (0e99.7) 0.234
Sample size
100 subjects 9 37.1 (20.8e55.2) 5 21.4 (12.4e32.1) 1
<100 subjects 15 60.8 (48.4e72.5) 0.034 10 52.8 (29.3e75.7) 0.015 8
Quality score
<50% 10 54.7 (32.1e76.4) 5 47.1 (8.4e88.0) 4 77 (54.5e93.7)
50% 14 49.2 (37.3e61.2) 0.677 10 38.5 (24.7e53.4) 0.726 5 6.0 (2.4e10.9) <0.0001
Case deﬁnition
Knee OA 14 58.7 (47e69.9) 12 49 (30.5e67.6) 7 43.8 (11.7e79.0)
Knee pain 5 26 (5.6e54.4) 0.037 3 15.2 (3.3e33.3) 0.010 2 4.8 (1.9e8.7) 0.009
Study design
Cross-sectional 11 43.0 (28.0e58.0) 5 25.0 (17.0e34.0) 2 4.0 (2.0e8.0)
Case-control 13 59.0 (41.0e76.0) 0.180 10 50.0 (24.0e76.0) 0.07 7 44.0 (13.0e78.0) <0.0001
Doppler settings
Colour doppler 2 87.0 (80.0e92.0)
Power doppler 7 20.0 (4.0e42.0)
Not stated 1 6.0 (3.0e12.0) <0.0001
Mean age
60 9 53.0 (42.0e63.0) 5 24.0 (13.0e38.0) 1
>60 13 61.0 (47.0e74.0) 0.070 9 55.0 (28.0e80.0) 0.050 7
Women proportion
70 8 51.0 (29.0e73.0) 7 31.0 (16.0e49.0) 7
>70 14 59.0 (48.0e70.0) 0.520 7 58.0 (30.0e84.0) 0.110 1
* P-test for heterogeneity between subgroups.
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However this study does not allow us to draw a strong conclusion.
Discussion
This is the ﬁrst meta-analysis of US detected synovial changes in
people with and without knee OA/pain. Twenty-nine observational
studies including 4720 participants from different countries wereFig. 2. Forest plot showing the subgroup analysis by overall quality score for the prevalenc
conﬁdence limits of the 95% conﬁdence interval around the mean prevalence rate. The diamo
CIs. Three groups from the study by Hall were included: (1) e people with symptomatic Oincluded in this study. The main ﬁndings are: [1] the prevalence of
US detected effusion, synovial hypertrophy and positive DS are 2e3
times higher in people with knee OA/pain than in the general
population or asymptomatic control groups; and [2] the US ab-
normalities relate more to presence of OA structural change than to
pain.
People with knee OA had signiﬁcantly higher prevalence of
effusion, synovial hypertrophy and DS than people with knee paine of DS in people with knee OA/pain. P e prevalence rates, 95% CI e lower and upper
nd in the forest plot denotes the summary prevalence and its edges the respective 95%
A, (2) e people with radiographic OA, (3) e people with knee pain.
Table IV
Associations between effusion and synovial hypertrophy with pain
Author, year Sample
size
Mean age
(SD/range)
Proportion of
women
Standardised quality score
(% of the maximum score)
Association between effusion and pain Association between synovial
hypertrophy and pain
Bevers 2014* 180 57 (9.2) 66.7 50 No association No association
Song 2008 41 65 (6.7) 63.4 22.2 No association No association
Ulasli 2014 86 56.2 (10.2) 80.2 60.0 No association
Hall 2014 62 73.9 (7.8) 67.7 55.6 Positive association Positive association
D'Agostino 2005* 600 66.7 (9.8) 72.5 90.0 Positive association No association
Malas 2014 61 58.88 (7.2) 83.6 40.0 Positive association
Mendieta 2006 101 62.1 (9) 70.0 70.0 Positive association with pain on motion
Chan 2014 193 59 (13.9) 74.1 60.0 Positive association with pain on walking,
but not while sitting
Positive association with pain while
sitting, but not walking
Wu 2012* 56 62.9 (8.2) 75.0 66.7 Positive association with pain during
movement, but not at rest
No association with pain on
movement and at rest
Naredo 2005 50 64.3 (7.9) 88.0 55.6 Positive association with pain during
movement and at rest
% positivity 7/10 2/6
* Adjusted for radiographic severity.
A. Sarmanova et al. / Osteoarthritis and Cartilage 24 (2016) 1376e1383 1381(P¼ 0.037, P¼ 0.010 and P¼ 0.009, respectively) (Table II). This may
be contrary to general expectation since the three US features
selected are widely considered to reﬂect inﬂammation and pain in
knee OA is suggested to associate with inﬂammation43,44. Impor-
tantly, however, this ﬁnding suggests that US detected synovial
change (effusion, hypertrophy, DS) may mainly correlate with the
degree of OA structural change and pathology, which increasingly is
recognised to involve all tissues that comprise the joint, rather than
represents a biomarker/mechanism that links strongly with pain
production.
There was signiﬁcant heterogeneity between studies with
respect to prevalence of all three US features. Such heterogeneity is
to be expected because a systematic review brings together studies
that are diverse both clinically and methodologically (e.g., thresh-
olds of abnormality, recruitment source, sample size, age, gender
proportion, BMI, disease duration, deﬁnition of knee OA/pain). For
example, among studies in people with knee OA/pain the subgroup
analysis revealed that studies with quality scores lower than 50% of
maximum presented signiﬁcantly higher prevalence of DS
(P < 0.0001), and studies with sample size less than 100 reported
signiﬁcantly higher prevalence of effusion and synovial hypertro-
phy (P¼ 0.034 and P¼ 0.015, respectively). This suggests that small
studies tend to inﬂate the results e the small study effect21,45. Care
must be taken when interpreting the results from such studies as
they may overestimate the prevalence of abnormalities.
The second research question was to determine relationships
between US features and knee pain. The majority of studies re-
ported a positive association between presence of effusion and
knee pain (7 out of 10) but no association between synovial hy-
pertrophy and pain (2 out of 6) (Table IV). US-detected ﬁndings
were also associated with structural changes on X-ray in two of the
three studies30,32,42. However, our subgroup analysis according to
knee pain and knee OA suggests that these three US abnormalities
relate to knee OA (either ACR symptomatic or radiographic) more
than knee pain. Further study is required to explain this ﬁnding.
A paucity of information was found on the prevalence of US-
detected changes in the general population and no prospective
community studies were identiﬁed. Considering gender differences
and possible associations between normal values and changes in
the musculoskeletal system and body composition with increasing
age the normal values of US detected synovial characteristics are
essential for the classiﬁcation and diagnosis of people with knee
pain and OA. It is expected that the normal values for older adults
might differ from those for younger people, since age-related
changes contribute to alterations in cartilage morphology, propri-
oception and muscle weakness even in the absence of OA. Forexample, in the Framingham study the prevalence of effusion/sy-
novitis on MRI in people without knee OA was 37% if the present/
absent scale was applied but only 4% if deﬁned by WORMS grade
two or more. Such synovitis was detected signiﬁcantly more often
in men than women (6% and 3%, respectively; P ¼ 0.02), but there
was no difference in relation to presence of knee pain or BMI46.
However, at present the characteristics of US-detected synovial
abnormalities especially in older age groups remains unknown.
There are several limitations to this study. Firstly, we focused
only on the knee, so the results cannot be extrapolated to other
joints. Secondly, there was signiﬁcant heterogeneity in the results
on prevalence, so the results of this review need to be interpreted
with caution. For example, differences in scanning technique were
common within included studies (e.g., neutral vs ﬂexed knee po-
sition, multi-planar vs midline scan (Supplementary ﬁle 3)) which
might affect the results and together with differences in participant
characteristics (age, gender, disease duration, severity of structural
changes) might explain some of the between-study heterogene-
ity40,47,48. Thirdly, the prevalence in the general population was
obtained from just a few studies including controls from case
control studies. This group is neither a random sample of the
general population, nor comparable to the cases with knee OA/pain.
The prevalence obtained from such an assembled “normal” control
group cannot be extrapolated to the prevalence in the general
population.
Our study highlights the lack of information on the presence of
synovial change in the knee. Although many studies have explored
this question, none has investigated the distribution of these fea-
tures in the general population, hence the threshold for abnor-
mality has yet to be established. US-detected pathology should be
described in detail and studies should provide sufﬁcient informa-
tion on deﬁnition and thresholds used. The heterogeneity across
studies highlights the need for a standard protocol in order to allow
comparability between studies in the future.
In conclusion, US detected effusion, synovial hypertrophy and
DS are more common in people with knee OA/pain, compared to
the general population. These abnormalities relate more to pres-
ence of OA structural changes than to pain. Further studies on the
reasons of this difference, normal values of the US features and
their thresholds of abnormalities are warranted.
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